Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $1.68M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
4,900% more call options, than puts
Call options by funds: $300K | Put options by funds: $6K
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
13% less funds holding
Funds holding: 8 → 7 (-1)
22% less capital invested
Capital invested by funds: $2.16M → $1.68M (-$473K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.13M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$206K |
| 3 |
Jane Street
New York
|
+$62.7K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$3.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$276K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$144K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$44K |
| 4 |
AIM
Anchor Investment Management
Columbia,
South Carolina
|
-$12.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $801K | +$1.13M | +40,030 | New |
|
|
2
Jane Street
New York
| $321K | +$62.7K | +2,216 | +16% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $290K | +$206K | +7,293 | +101% |
|
|
VF
4
Virtu Financial
New York
| $240K | -$276K | -9,743 | -45% |
|
5
Morgan Stanley
New York
| $16K | – | – | – |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
|
7
Simplex Trading
Chicago,
Illinois
| $2K | +$3.82K | +135 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$144K | -3,269 | Closed |
|
|
9
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$44K | -1,000 | Closed |
|
|
AIM
10
Anchor Investment Management
Columbia,
South Carolina
| – | -$12.2K | -275 | Closed |
|
UBIO Hedge Fund Activity: Q4 2018 in Review
7 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Proshares UltraPro NASDAQ Biotechnology (UBIO) for Q4 2018, worth a combined $1.68M — down 22% from $2.16M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of UBIO and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.13M. The largest seller was Virtu Financial, cutting an estimated $276K.
- 7 institutional investors held Proshares UltraPro NASDAQ Biotechnology (UBIO) as of Q4 2018, down from 8 in Q3 2018.
- Funds reported $1.68M of Proshares UltraPro NASDAQ Biotechnology stock for Q4 2018, down 22% quarter-over-quarter.
- 2 funds opened new Proshares UltraPro NASDAQ Biotechnology positions in Q4 2018 and 3 closed out, a net change of -1 holder.
- The largest Proshares UltraPro NASDAQ Biotechnology buyer in Q4 2018 was Susquehanna International Group, an estimated $1.13M added.
- The largest Proshares UltraPro NASDAQ Biotechnology seller in Q4 2018 was Virtu Financial, an estimated $276K sold.
Based on aggregated 13F filings for Q4 2018.